NCT06072911

Brief Summary

The Continence, Sexual and Metabolic Health (CONTROL 4 LIFE) study will evaluate the recovery of continence, sexual function, and health outcomes in individuals who have undergone surgery for prostate cancer. The purpose of this study is to better understand the timelines of recovery for these outcomes after surgery for prostate cancer. As part of this study, all participants will receive resources offered by Alberta Health Services regarding pre- and post-prostatectomy care, including information on pelvic floor exercises. Through the CONTROL 4 LIFE study, the investigators will also be evaluating outcomes related to physical activity, fitness and quality of life. These assessments will enable the investigators to better understand how well and how long it takes for individuals to recover after surgery for prostate cancer.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable prostate-cancer

Timeline
1mo left

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Feb 2024Jun 2026

First Submitted

Initial submission to the registry

September 12, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

October 10, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

February 27, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

January 30, 2026

Status Verified

January 1, 2026

Enrollment Period

2.2 years

First QC Date

September 12, 2023

Last Update Submit

January 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Completion Rate

    The number of participants completing the study including all planned outcomes

    Final assessment at one year

Secondary Outcomes (19)

  • Recruitment rate

    One year

  • Adherence rate

    Post-intervention: 12 weeks

  • 24-hour pad test

    24 hours at two time points: immediate post surgery and 12 weeks

  • Expanded Prostate Cancer Index Composite for Clinical Practice

    One-year

  • International Consultation on Incontinence Questionnaire

    One-year

  • +14 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Pelvic floor exercise program and general exercise programming

Behavioral: Pelvic floor exercise programBehavioral: General exercise

Control

ACTIVE COMPARATOR

Pelvic floor exercises and standard care (physical activity counseling)

Behavioral: Pelvic floor exercise programBehavioral: Physical Activity Counseling

Interventions

General exercises will be prescribed along with a specialized pelvic floor program

ControlIntervention

A general progressive resistance exercise program

Intervention

Advice on increasing physical activity

Control

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have a diagnosis of prostate cancer (stage I to IV);
  • be scheduled for a prostatectomy surgery (any surgical approach);
  • have no restriction to participate in at least mild levels of physical activity, as confirmed by the Physical Activity Readiness Questionnaire (PAR-Q+);
  • speak and understand English.
  • adult: 18 years of age or older
  • optional exercise component: willing and able to commit to the 12-week intervention

You may not qualify if:

  • have any medical conditions that may interfere with continence (i.e. neurological diseases);
  • have any contraindications to exercise testing or training;
  • have recent (\>6 months) modifications to any medication aiming to reduce urinary incontinence (i.e. Myrbetric);
  • do not have regular access to the internet and a smart device or a computer at home/ at their community center;
  • are already receiving a pelvic floor exercise program through a pelvic floor physical therapist from their community.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta

Edmonton, Alberta, T6G 2G4, Canada

RECRUITING

Related Publications (1)

  • Bernard S, Evans H, Hoy NY, Suderman K, Cameron B, Sexsmith J, Kinnaird A, Rourke K, Dean L, Pituskin E, Usmani N, Tandon P, McNeely ML. Control4Life: A randomized controlled trial protocol examining the feasibility and efficacy of a combined pelvic health rehabilitation and exercise fitness program for individuals undergoing prostatectomy. Contemp Clin Trials. 2024 Apr;139:107482. doi: 10.1016/j.cct.2024.107482. Epub 2024 Feb 29.

MeSH Terms

Conditions

Prostatic NeoplasmsMetabolic Diseases

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesNutritional and Metabolic Diseases

Study Officials

  • Nathan Hoy, MD

    University of Alberta

    PRINCIPAL INVESTIGATOR
  • Howard Evans, MD

    University of Alberta

    PRINCIPAL INVESTIGATOR
  • Margaret McNeely

    University of Alberta

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Margaret L McNeely

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants will be randomized after the baseline assessment and will have the option to take part in an additional exercise intervention component.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Zelen design with randomization
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 12, 2023

First Posted

October 10, 2023

Study Start

February 27, 2024

Primary Completion

April 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

January 30, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Data will be housed on the University of Alberta\'s Dataverse

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Following completion of the study and primary publication.

Locations